Cannabis- Hemp and Marijuana

Transcripts of Senate Hearings on Hemp:

  1. FDA
  2. Hemp Farmer
  3. THC Test
  4. Tribal Perspective
  5. USDA
  6. EPA

Hemp: AAPCO letter to the U.S. Senate

AAPCO to FDA: Comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds

Colorado Department of Agriculture and Colorado Department of Public Health & Environment, Joint Letter to FDA: Comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds

Docket: FDA’s Request for Comments (due July 16, 2019): Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds: Public Hearing

Department of Health and Human Services June 7, 2019 Memo and Links to Webinars (you will need to copy and paste the links to the session you are interested in, and have adobe connect to view the webinar):

 

 

June 7, 2019

 

 

Dear Colleague:

 

On behalf of the U.S. Food and Drug Administration (FDA), the Office of External Affairs, Stakeholder Engagement Staff, thanks you for your participation at the FDA’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing held on Friday, May 31, 2019. Your participation was essential to enhance our awareness of the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.

 

Opening remarks by Norman E. “Ned” Sharpless MD, Acting Commissioner of Food and Drugs, are available at:https://www.fda.gov/news-events/speeches-fda-officials/remarks-dr-sharpless-fda-public-hearing-scientific-data-and-information-about-products-containing.

A recording of the entire hearing is available in four distinct segments. Each segment is in order based on the hearing’s agenda. Event materials are available at: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds.

 

We plan to publish the hearing transcript and slide decks in approximately 30 days athttps://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds.

 

Please remember to submit your comments and supporting data to the docket atFDA-2019-N-1482by 11:59 p.m. (ET), Tuesday, July 2, 2019.

 

Again, thank you for your interest related to products containing cannabis or cannabis-derived compounds and we look forward to your continued participation on this topic.

 

Sincerely,

 

Stakeholder Engagement Staff

Office of External Affairs

U.S. Food and Drug Administration

 

Department of Justice Memo to US Attorney’s on Marijuana Enforcement, January 2018

Oregon Governor Brown’s statement regarding the DOJ memo, January 2018


OMRI Response to Oregon’s Pesticide Advisory, November 2017

Oregon issues 5 SSURO’s for adulterated products used on cannabis, August 2017:

HIT Manufacturing; Advanced NutrientsPure Life Veganix Vegamatrix 1 0 1 Boost CaMg w PolysaccharidesAssertive Assimilation Snoops Premium Nutrients 0 0 0.04 Radical Roots;Emerald Harvest

Special Local Need registrations for pesticides

May 2015     EPA to Colorado: Special Local Needs Registrations for pesticide uses for legal marijuana production in Colorado

June 2017     EPA’s Administrator to States: EPA intent to deny Special Local Needs Registrations for Cannabis, Intent to Disapprove


State Specific Cannabis information and websites

California Department of Pesticide Regulation Cannabis Policy

Oregon’s Cannabis webpage